Instituto de Investigación Sanitaria INCLIVA and Universidad de Valencia

Our research group in «Medical Chemistry for Drug Development» is mainly focused on the synthesis and isolation of new bioactive molecules of natural or synthetic origin. Our target is to collaborate with biologists and pharmacologists in order to carry out the hit-to-lead strategy and preclinical development. In addition, we have a mass spectrometry platform (UHPLC-MS/MS) that allows us the targeted identification and quantification of metabolites and biomarkers in extracts or biological samples.